文献速递甲状腺疾病

低风险甲状腺癌患者的管理方法

Approach to the patient with low-risk thyroid cancer.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

2025年美国甲状腺协会(ATA)成人分化型甲状腺癌管理指南聚焦低至高危患者的诊疗,强调低风险患者应共享决策、对无复发者降阶治疗及长期生存照护。本文通过3例低风险分化型甲状腺癌病例展示管理选择与关键考量。

要点

  • 多数分化型甲状腺癌患者为低风险疾病。
  • 低风险患者管理强调共享决策与降阶治疗。
  • 无复发患者需长期生存照护。

核心结论

  • 2025 ATA指南强调低风险分化型甲状腺癌患者应共享决策、对无复发者降阶治疗并重视长期生存照护。

研究设计与样本

  • 本文为病例展示,呈现3例低风险分化型甲状腺癌患者以说明管理选项与关键考量。

主要发现

  • 多数分化型甲状腺癌患者诊断为低风险疾病。

临床怎么用

  • 对低风险分化型甲状腺癌患者,临床应实践共享决策、对无复发者考虑降阶治疗并提供长期生存照护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The 2025 American Thyroid Association (ATA) Management Guidelines for Adult Patients with Differentiated Thyroid Cancer focus on the care of patients with low- to high-risk disease with management recommendations reflecting the evolving evidence in the field. Most patients diagnosed with differentiated thyroid cancer have low-risk disease. For the care of patients with low-risk disease, the new clinical guidelines emphasize shared decision-making, de-escalating care in patients who are recurrence free, and long-term survivorship care. We present 3 cases of patients with diagnoses of low-risk differentiated thyroid cancer to illustrate management options and key considerations.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Pitt SC, Haymart MR. Approach to the patient with low-risk thyroid cancer. J Clin Endocrinol Metab. 2026. PMID: 42338425. doi:10.1210/clinem/dgag243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。